Expertise in
37
conditions

Dr. Thomas E. Sepe

Gastroenterology
Daniel Quirk MD Inc.
33 Staniford St, 
Providence, RI 
Offers Telehealth
Expertise in
37
conditions
Daniel Quirk MD Inc.
33 Staniford St, 
Providence, RI 

Overview

Thomas Sepe is a Gastroenterologist practicing medicine in Providence, Rhode Island.

Dr. Sepe is highly rated in 37 conditions, according to our data. His clinical expertise encompasses Non-Alcoholic Fatty Liver Disease, Visceromegaly, Hepatitis C, Gastroesophageal Reflux Disease (GERD), and Endoscopy.

He is actively involved in clinical research, co-authoring 10 peer reviewed articles and participating in 5 clinical trials.

Specialties

Gastroenterology

Licenses

Internal Medicine in RI

Hospital Affiliations

The Miriam Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetLife
  • PPO
Neighborhood
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

Daniel Quirk MD Inc.
33 Staniford St, Providence, RI 02905

Additional Areas of Focus

Dr. Sepe has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 2 Open Label, Proof of Concept Study of HTD1801 (BUDCA) in Adult Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to Standard Therapy - PRONTO-PBC
A Phase 2 Open Label, Proof of Concept Study of HTD1801 (BUDCA) in Adult Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to Standard Therapy - PRONTO-PBC
Enrollment Status: Completed
Publish Date: August 25, 2026
Intervention Type: Drug
Study Drug: HTD1801 (BUDCA)
Study Phase: Phase 2
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects With Nonalcoholic Steatohepatitis
Enrollment Status: Terminated
Publish Date: October 01, 2024
Intervention Type: Drug
Study Drug: Obeticholic Acid
Study Phase: Phase 3
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Enrollment Status: Completed
Publish Date: October 23, 2023
Intervention Type: Drug
Study Drug: Obeticholic acid
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602K in Patients With NASH (EMMINENCE™)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, 12-Month, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602K in Patients With NASH (EMMINENCE™)
Enrollment Status: Completed
Publish Date: September 16, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Emricasan, an Oral Caspase Inhibitor, in Subjects With Decompensated Non-Alcoholic Steatohepatitis (NASH) Cirrhosis
Enrollment Status: Unknown
Publish Date: March 19, 2019
Intervention Type: Drug
Study Drug: Emricasan
Study Phase: Phase 2
View 4 Less Clinical Trials

10 Total Publications

Gastrointestinal Stromal Tumor Complicated by Fistula Formation.
Gastrointestinal Stromal Tumor Complicated by Fistula Formation.
Journal: ACG case reports journal
Published: May 09, 2023
Similar Doctors
Expertise in
18
conditions
Dr. Gilaad G. Kaplan
Gastroenterology
Expertise in
18
conditions
Dr. Gilaad G. Kaplan
Gastroenterology
Referral may be required

Massachusetts General Hospital

55 Fruit St, 
Boston, MA 
 (42.2 miles away)
617-726-3673
Languages Spoken:
English

Gilaad Kaplan is a Gastroenterologist practicing medicine in Boston, Massachusetts. Dr. Kaplan is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Viral Gastroenteritis, Crohn's Disease, Colitis, Endoscopy, and Colonoscopy.

Expertise in
36
conditions
Dr. Walter W. Chan
Gastroenterology
Expertise in
36
conditions
Dr. Walter W. Chan
Gastroenterology
Referral may be required

Brigham And Women's Hospital

75 Francis St, 
Boston, MA 
 (39.7 miles away)
617-732-6389
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Walter Chan is a Gastroenterologist practicing medicine in Boston, Massachusetts. Dr. Chan is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Gastroesophageal Reflux Disease (GERD), Esophagitis, Eosinophilic Esophagitis, Endoscopy, and Gastric Bypass. Dr. Chan is currently accepting new patients.

Expertise in
16
conditions
Dr. Hamed Khalili
Gastroenterology
Expertise in
16
conditions
Dr. Hamed Khalili
Gastroenterology
Referral may be required

Office

165 Cambridge St Fl 9, 
Boston, MA 
 (42.2 miles away)
617-726-7933
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Hamed Khalili is a Gastroenterologist practicing medicine in Boston, Massachusetts. Dr. Khalili is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Ulcerative Colitis, Lymphocytic Colitis, Crohn's Disease, Colonoscopy, and Endoscopy. Dr. Khalili is currently accepting new patients.

Frequently Asked Questions about Dr. Thomas E. Sepe

How do I make an appointment with Dr. Thomas E. Sepe?

You can book an appointment with Dr. Thomas E. Sepe by calling their office at 401-421-8800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Thomas E. Sepe a top-rated expert for Non-Alcoholic Fatty Liver Disease?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Thomas E. Sepe is classified as an Distinguished expert for Non-Alcoholic Fatty Liver Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Thomas E. Sepe specialize in?

While Dr. Thomas E. Sepe is a Gastroenterology, they have specific expertise in Non-Alcoholic Fatty Liver Disease, Visceromegaly, and Hepatitis C. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Thomas E. Sepe participate in research or clinical trials?

Yes. Dr. Thomas E. Sepe has published 10 articles and abstracts on conditions like Non-Alcoholic Fatty Liver Disease. You can view a list of Dr. Thomas E. Sepe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Thomas E. Sepe accept my insurance?

Dr. Thomas E. Sepe accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 401-421-8800 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sepe's expertise for a condition
ConditionClose
    View All 11 Distinguished Conditions
    View All 26 Advanced Conditions
    View All 57 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile